India to United States: Lisinopril Export Trade Route
India has recorded 74 verified shipments of Lisinopril exported to United States, representing a combined trade value of $15.0M USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $202.7K USD. The leading Indian exporter is LUPIN LIMITED, which accounts for 97% of total export value with 56 shipments worth $14.5M USD. On the buying side, Lupin Pharmaceutical Inc is the largest importer in United States with $7.9M USD in purchases. The top 3 suppliers — LUPIN LIMITED, WATSON PHARMA PRIVATE LIMITED, MSN LIFE SCIENCES PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Lisinopril corridor is one of India's established pharmaceutical export routes, with 74 shipments documented worth a combined $15.0M USD. The route is dominated by LUPIN LIMITED, which alone accounts for roughly 97% of all export value, reflecting the consolidated nature of India's lisinopril manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $202.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with lisinopril's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 15.1%, placing it at rank #20 among India's top lisinopril export destinations globally.
On the import side, key buyers of Indian lisinopril in United States include Lupin Pharmaceutical Inc, XXPINXXHARXXCEUXXCALXXINC, XXALLXXT PXXRMAXXUTIXXLS XXALTXXLLCX and 10 others. Lupin Pharmaceutical Inc is the single largest importer with 28 shipments valued at $7.9M USD.
Route Characteristics
- Average transit
